South East Genomics

South East Genomics

Translated resources for patients

Whole Genome Sequencing (WGS)

Record of Discussion (RoD) forms and patient information leaflets have been translated into a number of languages to aid patients when consenting to WGS. 

WGS Record of Discussion form

Patient information for Cancer

Patient information for Cancer (easy read version)

Patient information for Rare Disease

Patient information for Rare Disease (easy read version)

WGS Record of Discussion form

Patient information for Cancer

Patient information for Cancer (easy read version)

Patient information for Rare Disease

Patient information for Rare Disease (easy read version)

WGS Record of Discussion form

Patient information for Cancer

Patient information for Cancer (easy read version)

Patient information for Rare Disease

Patient information for Rare Disease (easy read version)

WGS Record of Discussion form

Patient information for Cancer

Patient information for Cancer (easy read version)

Patient information for Rare Disease

Patient information for Rare Disease (easy read version)

WGS Record of Discussion form

Patient information for Cancer

Patient information for Cancer (easy read version)

Patient information for Rare Disease

Patient information for Rare Disease (easy read version)

WGS Record of Discussion form

Patient information for Cancer

Patient information for Cancer (easy read version)

Patient information for Rare Disease

Patient information for Rare Disease (easy read version)

WGS Record of Discussion form

Patient information for Cancer

Patient information for Cancer (easy read version)

Patient information for Rare Disease

Patient information for Rare Disease (easy read version)

WGS Record of Discussion form

Patient information for Cancer (easy read version)

Patient information on Genomic Research

WGS Record of Discussion form

Patient information for Cancer

Patient information for Cancer (easy read version)

Patient information for Rare Disease

Patient information for Rare Disease (easy read version)

WGS Record of Discussion form

Patient information for Cancer

Patient information for Cancer (easy read version)

Patient information for Rare Disease

Patient information for Rare Disease (easy read version)

WGS Record of Discussion form

Patient information for Cancer

Patient information for Cancer (easy read version)

Patient information for Rare Disease

Patient information for Rare Disease (easy read version)

About Us

GMS Alliance

Genomic Laboratory Hub

Patients and Public

Educational Resources

News and Events

© South East Genomics 2020

Privacy and Terms

Twitter
Contact us

Critical incident affecting genomics tests from Viapath

The issues with our IT systems have now been resolved  and our laboratory is processing all tests and referrals sent to us.

Please be aware that as normal services resume you may experience some delays to receiving results and the reports may look different.

With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here. 
 
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
 
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
 
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.